These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6285063)

  • 1. Steroid hormone receptors in the rat mammary adenocarcinoma induced by N-hydroxy-N-2-fluorenylacetamide.
    Li SA; Malejka-Giganti D; Li JJ
    J Natl Cancer Inst; 1982 Jul; 69(1):41-5. PubMed ID: 6285063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.
    Wittliff JL; Mehta RG; Boyd PA; Goral JE
    J Toxicol Environ Health Suppl; 1976; 1():231-56. PubMed ID: 186628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid-hormone-binding proteins in normal and neoplastic mammary tissues from C3H mice fed diethylstilbestrol.
    Lewko WM; Wittliff JL
    J Toxicol Environ Health; 1983 Jul; 12(1):127-41. PubMed ID: 6632000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.
    Pollack A; Irvin GL; Block NL; Lipton RM; Stover BJ; Claflin AJ
    Cancer Res; 1982 Jun; 42(6):2184-90. PubMed ID: 7074599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of progesterone-binding components in neoplastic mammary tissues of the rat.
    Goral JE; Wittliff JL
    Cancer Res; 1976 Jun; 36(6):1886-93. PubMed ID: 178435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the estrous cycle during carcinogen exposure on nitrosomethylurea-induced rat mammary carcinoma.
    Lindsey WF; Das Gupta TK; Beattie CW
    Cancer Res; 1981 Oct; 41(10):3857-62. PubMed ID: 7197191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptors in feline mammary adenocarcinomas.
    Johnston SD; Hayden DW; Kiang DT; Handschin B; Johnson KH
    Am J Vet Res; 1984 Feb; 45(2):379-82. PubMed ID: 6711965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor characteristics of the rat mammary carcinoma cell line 64-24.
    Eil C; Douglass EC; Rosenburg SM; Kano-Sueoka T
    Cancer Res; 1981 Jan; 41(1):42-8. PubMed ID: 6256064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
    Malejka-Giganti D; Rydell RE; Gutmann HR
    Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxidative metabolism of a carcinogen, N-hydroxy-N-2-fluorenylacetamide, by rat uterus and mammary gland in vitro.
    Malejka-Giganti D; Ritter CL; Decker RW; Suilman JM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6200-6. PubMed ID: 3779640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor characteristics of specific estrogen binding in the renal adenocarcinoma of the golden hamster.
    Li JJ; Talley DJ; Li SA; Villee CA
    Cancer Res; 1976 Mar; 36(3):1127-32. PubMed ID: 175953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ovariectomy on hormone receptors and growth of N-nitrosomethylurea-induced mammary tumors in the rat.
    Arafah BM; Gullino PM; Manni A; Pearson OH
    Cancer Res; 1980 Dec; 40(12):4628-30. PubMed ID: 6254648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor in the "non-lymphocytes" in the thymus of the ovariectomized rat.
    Haruki Y; Seiki K; Enomoto T; Fujii H; Sakabe K
    Tokai J Exp Clin Med; 1983 Jan; 8(1):31-9. PubMed ID: 6612751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of certain N-arylacetamides and N-arylacetohydroxamic acids in relation to mammary gland tumorigenesis in the rat.
    Malejka-Giganti D
    Natl Cancer Inst Monogr; 1981 Dec; (58):69-77. PubMed ID: 6804871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C; Shan L; Yu M; Snyderwine EG
    Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation.
    Allaben WT; Weeks CE; Weis CC; Burger GT; King CM
    Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.